<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Insulin resistance,Articles with unsourced statements since December 2008,Endocrine pathology,Congenital endocrine disorders,Endocrine gland neoplasia,17-beta-hydroxysteroid dehydrogenase deficiency,5-alpha-reductase deficiency,Acidosis,Acromegaly,Acute infectious thyroiditis,Addison&#039;s disease" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Insulin_resistance&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Insulin_resistance&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Insulin resistance - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Insulin_resistance";
		var wgTitle = "Insulin resistance";
		var wgAction = "view";
		var wgArticleId = "54448";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 276088448;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Insulin_resistance skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Insulin resistance</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table class="infobox" width="200" cellspacing="0" style="font-size: 95%; text-align:left">
<tr>
<td style="text-align: center; background: lightgrey; font-size: 95%;" colspan="2"><b>Insulin resistance</b><br />
<i>Classification and external resources</i></td>
</tr>
<tr>
<th><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/med/topic1173.htm" class="external text" title="http://www.emedicine.com/med/topic1173.htm" rel="nofollow">med/1173</a>&#160;</td>
</tr>
<tr>
<td><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b></td>
<td colspan="2"><i><a href="http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&amp;term=Insulin+Resistance&amp;field=entry#TreeC18.452.394.968.500" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&amp;term=Insulin+Resistance&amp;field=entry#TreeC18.452.394.968.500" rel="nofollow">C18.452.394.968.500</a></i></td>
</tr>
</table>
<p><b>Insulin resistance</b> (IR) is the condition in which normal amounts of <a href="/wiki/Insulin" title="Insulin">insulin</a> are inadequate to produce a normal <a href="/wiki/Insulin#Physiological_effects" title="Insulin">insulin response</a> from <a href="/wiki/Fat" title="Fat">fat</a>, <a href="/wiki/Muscle" title="Muscle">muscle</a> and <a href="/wiki/Liver" title="Liver">liver</a> <a href="/wiki/Cell_(biology)" title="Cell (biology)">cells</a>. Insulin resistance in <a href="/wiki/Adipose_tissue" title="Adipose tissue">fat cells</a> reduces the effects of insulin and results in elevated <a href="/wiki/Hydrolysis" title="Hydrolysis">hydrolysis</a> of stored <a href="/wiki/Triglyceride" title="Triglyceride">triglycerides</a> in the absence of measures which either increase insulin sensitivity or which provide additional insulin. Increased mobilization of stored lipids in these cells elevates free <a href="/wiki/Fatty_acid" title="Fatty acid">fatty acids</a> in the <a href="/wiki/Blood_plasma" title="Blood plasma">blood plasma</a>. Insulin resistance in muscle cells reduces <a href="/wiki/Glucose" title="Glucose">glucose</a> uptake (and so local storage of glucose as <a href="/wiki/Glycogen" title="Glycogen">glycogen</a>), whereas insulin resistance in liver cells results in impaired glycogen synthesis and a failure to suppress glucose production. Elevated blood fatty acid levels (associated with insulin resistance and diabetes mellitus Type 2), reduced muscle glucose uptake, and increased liver glucose production all contribute to elevated blood glucose levels. High plasma levels of insulin and glucose due to insulin resistance are believed to be the origin of <a href="/wiki/Metabolic_syndrome" title="Metabolic syndrome">metabolic syndrome</a> and <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">type 2 diabetes</a>, including its complications.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Symptoms_of_IR"><span class="tocnumber">1</span> <span class="toctext">Symptoms of IR</span></a></li>
<li class="toclevel-1"><a href="#Pathophysiology"><span class="tocnumber">2</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1"><a href="#Investigation"><span class="tocnumber">3</span> <span class="toctext">Investigation</span></a>
<ul>
<li class="toclevel-2"><a href="#Fasting_Insulin_Levels"><span class="tocnumber">3.1</span> <span class="toctext">Fasting Insulin Levels</span></a></li>
<li class="toclevel-2"><a href="#Glucose_tolerance_testing_.28GTT.29"><span class="tocnumber">3.2</span> <span class="toctext">Glucose tolerance testing (GTT)</span></a></li>
<li class="toclevel-2"><a href="#Measuring_Insulin_Resistance"><span class="tocnumber">3.3</span> <span class="toctext">Measuring Insulin Resistance</span></a></li>
<li class="toclevel-2"><a href="#Alternatives"><span class="tocnumber">3.4</span> <span class="toctext">Alternatives</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Causes_of_insulin_resistance"><span class="tocnumber">4</span> <span class="toctext">Causes of insulin resistance</span></a></li>
<li class="toclevel-1"><a href="#Associated_Conditions"><span class="tocnumber">5</span> <span class="toctext">Associated Conditions</span></a></li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">6</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">7</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">8</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">10</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Symptoms_of_IR" id="Symptoms_of_IR"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=1" title="Edit section: Symptoms of IR">edit</a>]</span> <span class="mw-headline">Symptoms of IR</span></h2>
<ol>
<li>Fatigue.</li>
<li>Brain fogginess and inability to focus. Sometimes the fatigue is physical, but often it is mental.</li>
<li>High blood sugar.</li>
<li>Intestinal bloating. Most intestinal gas is produced from carbohydrates in the diet. Insulin resistance sufferers who eat carbohydrates sometimes suffer from gas.</li>
<li>Sleepiness. Many people with insulin resistance get sleepy immediately after eating a meal containing more than 20% or 30% carbohydrates.</li>
<li>Weight gain, fat storage, difficulty losing weight. For most people, too much weight is too much fat. The fat in IR is generally stored in and around abdominal organs in both males and females. It is currently suspected that hormonal effects from such fat are a precipitating cause of insulin resistance.</li>
<li>Increased blood triglyceride levels.</li>
<li>Increased blood pressure. Many people with hypertension are either diabetic or pre-diabetic and have elevated insulin levels due to insulin resistance. One of insulin's effects is on arterial walls throughout the body.</li>
<li>Depression. Because of the deranged metabolism resulting from insulin resistance, psychological effects are not uncommon. Depression is said to be the prevalent psychological symptom.</li>
</ol>
<p><a name="Pathophysiology" id="Pathophysiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=2" title="Edit section: Pathophysiology">edit</a>]</span> <span class="mw-headline">Pathophysiology</span></h2>
<p>In a person with normal metabolism, insulin is released from the beta (β) cells of the <a href="/wiki/Islets_of_Langerhans" title="Islets of Langerhans">Islets of Langerhans</a> located in the <a href="/wiki/Pancreas" title="Pancreas">pancreas</a> after eating ("postprandial"), and it signals insulin-sensitive tissues in the body (e.g., <a href="/wiki/Muscle" title="Muscle">muscle</a>, <a href="/wiki/Adipose" title="Adipose" class="mw-redirect">adipose</a>) to absorb <a href="/wiki/Glucose" title="Glucose">glucose</a>. This lowers blood glucose levels. The beta cells reduce their insulin output as blood glucose levels fall, with the result that blood glucose is maintained at approximately 5 mmol/L (mM) (90 mg/dL). In an <i>insulin-resistant</i> person, normal levels of insulin do not have the same effect on muscle and adipose cells, with the result that glucose levels stay higher than normal. To compensate for this, the pancreas in an insulin-resistant individual is stimulated to release more insulin. The elevated insulin levels have additional effects (see <a href="/wiki/Insulin" title="Insulin">insulin</a>) which cause further biological effects throughout the body.</p>
<p>The most common type of <a href="/wiki/Insulin" title="Insulin">insulin</a> resistance is associated with a collection of symptoms known as <a href="/wiki/Metabolic_syndrome" title="Metabolic syndrome">metabolic syndrome</a>. Insulin resistance can progress to full <a href="/wiki/Type_2_diabetes" title="Type 2 diabetes" class="mw-redirect">type 2 diabetes</a>. This is often seen when <a href="/wiki/Hyperglycemia" title="Hyperglycemia">hyperglycemia</a> develops after a meal, when pancreatic β-cells are unable to produce sufficient insulin to maintain normal blood sugar levels (<a href="/w/index.php?title=Euglycemia&amp;action=edit&amp;redlink=1" class="new" title="Euglycemia (page does not exist)">euglycemia</a>). The inability of the β-cells to produce sufficient insulin in a condition of hyperglycemia is what characterizes the transition from insulin resistance to type 2 diabetes.<sup id="cite_ref-McGarry_2002_0-0" class="reference"><a href="#cite_note-McGarry_2002-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p>Various disease states make the body tissues more resistant to the actions of insulin. Examples include <a href="/wiki/Infection" title="Infection">infection</a> (mediated by the cytokine <a href="/wiki/Tumor_necrosis_factor-alpha" title="Tumor necrosis factor-alpha">TNFα</a>) and <a href="/wiki/Acidosis" title="Acidosis">acidosis</a>. Recent research is investigating the roles of <a href="/wiki/Adipokine" title="Adipokine">adipokines</a> (the <a href="/wiki/Cytokine" title="Cytokine">cytokines</a> produced by <a href="/wiki/Adipose_tissue" title="Adipose tissue">adipose tissue</a>) in insulin resistance. Certain drugs may also be associated with insulin resistance (e.g., <a href="/wiki/Glucocorticoid" title="Glucocorticoid">glucocorticoids</a>).</p>
<p>Insulin itself can lead to insulin resistance; every time a cell is exposed to insulin, the production of <a href="/wiki/GLUT4" title="GLUT4">GLUT4</a> (type four glucose receptors) on the cell's membrane is decreased.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1" title=""><span>[</span>2<span>]</span></a></sup> This leads to a greater need for insulin, which again leads to fewer glucose receptors. Exercise reverses this process in muscle tissue,<sup id="cite_ref-2" class="reference"><a href="#cite_note-2" title=""><span>[</span>3<span>]</span></a></sup> but if left unchecked, it can spiral into insulin resistance.</p>
<p>Elevated blood levels of glucose — regardless of cause — leads to increased <a href="/wiki/Glycation" title="Glycation">glycation</a> of <a href="/wiki/Protein" title="Protein">proteins</a> with changes (only a few of which are understood in any detail) in protein function throughout the body.</p>
<p>Insulin resistance is often found in people with visceral adiposity (i.e., a high degree of fatty tissue underneath the abdominal muscle wall - as distinct from subcutaneous adiposity or fat between the skin and the muscle wall, especially elsewhere on the body, such as hips or thighs), hypertension, hyperglycemia and <a href="/wiki/Dyslipidemia" title="Dyslipidemia">dyslipidemia</a> involving elevated triglycerides, small dense low-density lipoprotein (sdLDL) particles, and decreased HDL cholesterol levels. With respect to visceral adiposity, a great deal of evidence suggests two strong links with insulin resistance. First, unlike subcutaneous adipose tissue, visceral adipose cells produce significant amounts of proinflammatory <a href="/wiki/Cytokines" title="Cytokines" class="mw-redirect">cytokines</a> such as tumor necrosis factor-alpha (<a href="/wiki/TNF-a" title="TNF-a" class="mw-redirect">TNF-a</a>), and <a href="/wiki/Interleukins" title="Interleukins" class="mw-redirect">Interleukins</a>-1 and -6, etc. In numerous experimental models, these proinfammatory cytokines profoundly disrupt normal insulin action in fat and muscle cells, and may be a major factor in causing the whole-body insulin resistance observed in patients with visceral adiposity. A great deal of attention into the production of proinflammatory cytokines has focused on the IKK-beta/<a href="/wiki/NF-kappa-B" title="NF-kappa-B" class="mw-redirect">NF-kappa-B</a> pathway, a protein network that enhances transcription of cytokine genes. Second, visceral adiposity is related to an accumulation of fat in the liver, a condition known as nonalcoholic fatty liver disease (NAFLD). The result of NAFLD is an excessive release of free fatty acids into the bloodstream (due to increased lipolysis), and an increase in hepatic glucose production, both of which have the effect of exacerbating peripheral insulin resistance and increasing the likelihood of type-2 diabetes.</p>
<p>Insulin resistance is also often associated with a <a href="/wiki/Hypercoagulable_state" title="Hypercoagulable state" class="mw-redirect">hypercoagulable state</a> (impaired fibrinolysis) and increased inflammatory cytokine levels.</p>
<p>Insulin resistance is also occasionally found in patients who use insulin. In this case, the production of antibodies against insulin leads to lower-than-expected glucose level reductions (glycemia) after a specific dose of insulin. With the development of human insulin and analogues in the 1980s and the decline in the use of animal insulins (e.g., pork, beef), this type of insulin resistance has become uncommon.</p>
<p><a href="/wiki/Magnesium" title="Magnesium">Magnesium</a> (Mg) is present in living cells and its plasma concentration is remarkably constant in healthy subjects. Plasma and intracellular Mg concentrations are tightly regulated by several factors. Among them, insulin seems to be one of the most important. In vitro and in vivo studies have demonstrated that insulin may modulate the shift of Mg from extracellular to intracellular space. Intracellular Mg concentration has also been shown to be effective in modulating insulin action (mainly oxidative glucose metabolism), offset calcium-related excitation-contraction coupling, and decrease smooth cell responsiveness to depolarizing stimuli. A poor intracellular Mg concentration, as found in noninsulin-dependent diabetes mellitus (NIDDM) and in hypertensive patients, may result in a defective tyrosine-kinase activity at the insulin receptor level and exaggerated intracellular calcium concentration. Both events are responsible for the impairment in insulin action and a worsening of insulin resistance in noninsulin-dependent diabetic and hypertensive patients. By contrast, in NIDDM patients daily Mg administration, restoring a more appropriate intracellular Mg concentration, contributes to improve insulin-mediated glucose uptake. The benefits deriving- from daily Mg supplementation in NIDDM patients are further supported by epidemiological studies showing that high daily Mg intake are predictive of a lower incidence of NIDDM.</p>
<p><a name="Investigation" id="Investigation"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=3" title="Edit section: Investigation">edit</a>]</span> <span class="mw-headline">Investigation</span></h2>
<p><a name="Fasting_Insulin_Levels" id="Fasting_Insulin_Levels"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=4" title="Edit section: Fasting Insulin Levels">edit</a>]</span> <span class="mw-headline">Fasting Insulin Levels</span></h3>
<p>A fasting serum insulin level of greater than the upper limit of normal for the assay used (approximately 60 pmol/L) is considered evidence of insulin resistance.</p>
<p><a name="Glucose_tolerance_testing_.28GTT.29" id="Glucose_tolerance_testing_.28GTT.29"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=5" title="Edit section: Glucose tolerance testing (GTT)">edit</a>]</span> <span class="mw-headline">Glucose tolerance testing (GTT)</span></h3>
<p>During a <a href="/wiki/Glucose_tolerance_test" title="Glucose tolerance test">glucose tolerance test</a>, which may be used to diagnose diabetes mellitus, a fasted patient takes a 75 gram oral dose of glucose. Blood glucose levels are then measured over the following 2 hours.</p>
<p>Interpretation is based on WHO guidelines. After 2 hours a <a href="/wiki/Glycemia" title="Glycemia">Glycemia</a> less than 7.8 mmol/L is considered normal, a glycaemia of between 7.8 to 11.0 is considered as <a href="/wiki/Impaired_Glucose_Tolerance" title="Impaired Glucose Tolerance" class="mw-redirect">Impaired Glucose Tolerance</a> (IGT) and a glycaemia of greater than or equal to 11.1 is considered <a href="/wiki/Diabetes_Mellitus" title="Diabetes Mellitus" class="mw-redirect">Diabetes Mellitus</a>.</p>
<p>An OGTT can be normal or mildly abnormal in simple insulin resistance. Often, there are raised glucose levels in the early measurements, reflecting the loss of a postprandial (after the meal) peak in insulin production. Extension of the testing (for several more hours) may reveal a <a href="/wiki/Hypoglycemia" title="Hypoglycemia">hypoglycemic</a> "dip," which is a result of an overshoot in insulin production after the failure of the physiologic postprandial insulin response.</p>
<p><a name="Measuring_Insulin_Resistance" id="Measuring_Insulin_Resistance"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=6" title="Edit section: Measuring Insulin Resistance">edit</a>]</span> <span class="mw-headline">Measuring Insulin Resistance</span></h3>
<p><b>Hyperinsulinemic euglycemic clamp</b></p>
<p>The <a href="/wiki/Gold_standard_(test)" title="Gold standard (test)">gold standard</a> for investigating and quantifying insulin resistance is the "hyperinsulinemic euglycemic clamp," so-called because it measures the amount of <a href="/wiki/Glucose" title="Glucose">glucose</a> necessary to compensate for an increased <a href="/wiki/Insulin" title="Insulin">insulin</a> level without causing <a href="/wiki/Hypoglycemia" title="Hypoglycemia">hypoglycemia</a>.<sup id="cite_ref-Anders_1979_3-0" class="reference"><a href="#cite_note-Anders_1979-3" title=""><span>[</span>4<span>]</span></a></sup> The test is rarely performed in clinical care, but is used in medical research, for example, to assess the effects of different medications. The rate of glucose infusion is commonly referred to in diabetes literature as the GINF value.</p>
<p>The procedure takes about 2 hours. Through a <a href="/wiki/Peripheral_vein" title="Peripheral vein">peripheral vein</a>, <a href="/wiki/Insulin" title="Insulin">insulin</a> is infused at 10-120 mU per m<sup>2</sup> per <a href="/wiki/Minute" title="Minute">minute</a>. In order to compensate for the insulin <a href="/wiki/Intravenous" title="Intravenous" class="mw-redirect">infusion</a>, <a href="/wiki/Glucose" title="Glucose">glucose</a> 20% is infused to maintain blood sugar levels between 5 and 5.5 mmol/l. The rate of glucose infusion is determined by checking the <a href="/wiki/Blood_sugar" title="Blood sugar">blood sugar</a> levels every 5 to 10 minutes. Low-dose insulin infusions are more useful for assessing the response of the liver, whereas high-dose insulin infusions are useful for assessing peripheral (i.e., muscle and fat) insulin action.</p>
<p>The rate of glucose infusion during the last 30 minutes of the test determines insulin sensitivity. If high levels (7.5 mg/min or higher) are required, the patient is insulin-sensitive. Very low levels (4.0 mg/min or lower) indicate that the body is resistant to insulin action. Levels between 4.0 and 7.5 mg/min are not definitive and suggest "impaired glucose tolerance," an early sign of insulin resistance.</p>
<p>This basic technique can be significantly enhanced by the use of glucose tracers. Glucose can be labeled with either stable or radioactive atoms. Commonly-used tracers are 3-<sup>3</sup>H glucose (radioactive), 6,6 <sup>2</sup>H-glucose (stable) and 1-<sup>13</sup>C Glucose (stable). Prior to beginning the hyperinsulinemic period, a 3h tracer infusion enables one to determine the basal rate of glucose production. During the clamp, the plasma tracer concentrations enable the calculation of whole-body insulin-stimulated glucose metabolism, as well as the production of glucose by the body (i.e., endogenous glucose production).</p>
<p><b>Modified Insulin Suppression Test</b></p>
<p>Another measure of insulin resistance is the modified insulin suppression test developed by Gerald Reaven at Stanford University. The test correlates well with the euglycemic clamp with less operator-dependent error. This test has been used to advance the large body of research relating to the metabolic syndrome.</p>
<p>Patients initially receive 25 mcg of octreotide (Sandostatin) in 5 ml of normal saline over 3 to 5 min IV as an initial bolus, and then will be infused continuously with an intravenous infusion of somatostatin (0.27 μgm/m<sup>2</sup>/min) to suppress endogenous insulin and glucose secretion. Insulin and 20% glucose is then infused at rates of 32 and 267 mg/m<sup>2</sup>/min, respectively. Blood glucose is checked at zero, 30, 60, 90, and 120 minutes, and then every 10 minutes for the last half-hour of the test. These last 4 values are averaged to determine the steady-state plasma glucose level. Subjects with an SSPG greater than 150 mg/dl are considered to be insulin-resistant.</p>
<p><a name="Alternatives" id="Alternatives"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=7" title="Edit section: Alternatives">edit</a>]</span> <span class="mw-headline">Alternatives</span></h3>
<p>Given the complicated nature of the "clamp" technique (and the potential dangers of <a href="/wiki/Hypoglycemia" title="Hypoglycemia">hypoglycemia</a> in some patients), alternatives have been sought to simplify the measurement of insulin resistance. The first was the <a href="/wiki/Homeostatic_model_assessment" title="Homeostatic model assessment">Homeostatic Model Assessment</a> (HOMA), and a more recent method is the QUICKI (quantitative insulin sensitivity check index). Both employ <a href="/wiki/Fasting" title="Fasting">fasting</a> <a href="/wiki/Insulin" title="Insulin">insulin</a> and <a href="/wiki/Glucose" title="Glucose">glucose</a> levels to calculate insulin resistance, and both correlate reasonably with the results of clamping studies. Wallace <i>et al.</i> point out that QUICKI is the <a href="/wiki/Logarithm" title="Logarithm">logarithm</a> of the value from one of the HOMA equations.<sup id="cite_ref-Wallace_2004_4-0" class="reference"><a href="#cite_note-Wallace_2004-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p><a name="Causes_of_insulin_resistance" id="Causes_of_insulin_resistance"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=8" title="Edit section: Causes of insulin resistance">edit</a>]</span> <span class="mw-headline">Causes of insulin resistance</span></h2>
<p>The cause of the vast majority of cases of insulin resistance remains unknown. There is clearly an inherited component, as sharply increased rates of insulin resistance and Type 2 diabetes are found in those with close relatives who have developed Type 2 diabetes. However, there are some grounds for suspecting that insulin resistance is related to a high-carbohydrate diet. An American study has shown that <a href="/wiki/Glucosamine" title="Glucosamine">glucosamine</a> (often prescribed for joint problems) may cause insulin resistance.<sup id="cite_ref-Pham2007_5-0" class="reference"><a href="#cite_note-Pham2007-5" title=""><span>[</span>6<span>]</span></a></sup> Insulin resistance has also been linked to <a href="/wiki/PCOS" title="PCOS" class="mw-redirect">PCOS</a> (<u>p</u>oly<u>c</u>ystic <u>o</u>vary <u>s</u>yndrome) as either causing it or being caused by it. Further studies are in progress. Other studies have also linked to the increased amounts of fructose (e.g., in <a href="/wiki/HFCS" title="HFCS" class="mw-redirect">HFCS</a> — <u>h</u>igh <u>f</u>ructose <u>c</u>orn <u>s</u>yrup, currently the least expensive nutritive sweetener available in industrial quantities); in humans, fructose causes changes in blood lipid profiles, among other things, mostly due to its effects on liver function. The high amounts of ordinary sucrose (i.e., table sugar) in the typical developed-world diet is also suspected of having some causative effect on the development of insulin resistance (sucrose is 1/2 fructose, which may account for the effect, if any). Insulin resistance has certainly risen in step with the increase in sugar consumption and the substantial commercial usage of HFCS since its introduction to the food trades; the effect may also be due to other parallel diet changes however. Further research may distinguish between candidate causes. .</p>
<p>At the cellular level, excessive circulating insulin appears to be a contributor to insulin resistance via down-regulation of insulin receptors. This occurs due to prolonged and repeated elevations of circulating insulin.<sup id="cite_ref-titleEmergency_Medicine_6-0" class="reference"><a href="#cite_note-titleEmergency_Medicine-6" title=""><span>[</span>7<span>]</span></a></sup> Since the usual instances of Type 2 insulin resistance are distinct from pathological over production of insulin, this does not seem to be the typical cause of the insulin resistance leading to Type 2 diabetes mellitus, the largest clinical issue connected with insulin resistance. The presence of insulin resistance typically precedes the diagnosis of Types 2 diabetes mellitus, however, and as elevated blood glucose levels are the primary stimulus for insulin secretion and production, habitually excessive carbohydrate intake is a likely contributor. Additionally, some Type 2 cases require so much external insulin that this down-regulation contributes to total insulin resistance.</p>
<p>Inflammation also seems to be implicated in causing insulin resistance. Mice without <a href="/wiki/C-Jun_N-terminal_kinases" title="C-Jun N-terminal kinases">JNK1</a>-signaling do not develop insulin resistance under dietary conditions that normally produce it.<sup id="cite_ref-Solinas_7-0" class="reference"><a href="#cite_note-Solinas-7" title=""><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-titleDiabetes_News_from_dLife.com:_UCSD_Researchers_Discover_Inflammation.2C_Not_Obesity.2C_Cause_of_Insulin_Resistance_8-0" class="reference"><a href="#cite_note-titleDiabetes_News_from_dLife.com:_UCSD_Researchers_Discover_Inflammation.2C_Not_Obesity.2C_Cause_of_Insulin_Resistance-8" title=""><span>[</span>9<span>]</span></a></sup></p>
<p><a href="/wiki/Vitamin_D" title="Vitamin D">Vitamin D</a> deficiency is also associated with insulin resistance.<sup id="cite_ref-Chiu_2004_9-0" class="reference"><a href="#cite_note-Chiu_2004-9" title=""><span>[</span>10<span>]</span></a></sup></p>
<p>Some research has shed light on a complex interaction between elevated free fatty acids and inflammatory cytokines seen in obesity activating Protein Kinase C isoform theta. PKC Theta inhibits Insulin Receptor Substrate (IRS) activation and hence prevents glucose up-take in response to insulin.</p>
<p>Recent research and experimentation has uncovered a non-obesity related connection to insulin resistance and Type 2 diabetes. It has long been observed that patients who have had some kinds of bariatric surgery have increased insulin sensitivity and even remission of Type 2 diabetes. It was discovered that diabetic / insulin resistant non obese rats whose proximal small intestine and duodenum has been surgically removed also experienced increased insulin sensitivity and remission of Type 2 diabetes. This suggested similar surgery in humans, and early reports in prominent medical journals (January 08) are that the same effect is seen in humans, at least the small number who have participated in the experimental surgical program. The speculation is that some substance is produced in that portion of the small intestine which signals body cells to become insulin resistant. If the producing tissue is removed, the signal ceases and body cells revert to normal insulin sensitivity. No such substance has been found as yet, so its existence remains speculation.</p>
<p><a name="Associated_Conditions" id="Associated_Conditions"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=9" title="Edit section: Associated Conditions">edit</a>]</span> <span class="mw-headline">Associated Conditions</span></h2>
<p>Several associated conditions include</p>
<ul>
<li>Abnormally Sedentary Lifestyle, whether the result of the effects of <a href="/wiki/Aging" title="Aging" class="mw-redirect">aging</a> on the body or lack of physical exercise (both of which can also produce <a href="/wiki/Obesity" title="Obesity">obesity</a>)</li>
<li><a href="/wiki/Haemochromatosis" title="Haemochromatosis">Haemochromatosis</a></li>
<li><a href="/wiki/Polycystic_ovarian_syndrome" title="Polycystic ovarian syndrome" class="mw-redirect">Polycystic ovarian syndrome</a> (PCOS)</li>
<li><a href="/wiki/Hypercortisolism" title="Hypercortisolism" class="mw-redirect">Hypercortisolism</a> (e.g., <a href="/wiki/Steroid" title="Steroid">steroid</a> use or <a href="/wiki/Cushing%27s_disease" title="Cushing's disease" class="mw-redirect">Cushing's disease</a>)</li>
<li><a href="/wiki/Medication" title="Medication" class="mw-redirect">Drugs</a> (e.g., <a href="/wiki/Rifampicin" title="Rifampicin">rifampicin</a>, <a href="/wiki/Isoniazid" title="Isoniazid">isoniazid</a>, <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a>, <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>, <a href="/wiki/Progestogen" title="Progestogen" class="mw-redirect">progestogens</a>, many antiretrovirals, possibly <a href="/wiki/Alcohol" title="Alcohol">alcohol</a><sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup>, <a href="/wiki/Methadone" title="Methadone">methadone</a>)</li>
<li>Genetic causes
<ul>
<li><a href="/wiki/Insulin_receptor" title="Insulin receptor">Insulin receptor</a> mutations (<a href="/wiki/Donohue_Syndrome" title="Donohue Syndrome" class="mw-redirect">Donohue Syndrome</a>)</li>
<li><a href="/wiki/LMNA" title="LMNA">LMNA</a> mutations (<a href="/w/index.php?title=Familial_Partial_Lipodystrophy&amp;action=edit&amp;redlink=1" class="new" title="Familial Partial Lipodystrophy (page does not exist)">Familial Partial Lipodystrophy</a>)</li>
</ul>
</li>
</ul>
<p>Insulin resistance may also be caused by the damage of liver cells having undergone a defect of insulin receptors in hepatocytes.</p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=10" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<p>The primary treatment for insulin resistance is <a href="/wiki/Exercise" title="Exercise" class="mw-redirect">exercise</a> and <a href="/wiki/Weight_loss" title="Weight loss">weight loss</a>. Low-<a href="/wiki/Glycemic_index" title="Glycemic index">glycemic index</a> or low-carbohydrate diets have also been shown to help.<sup id="cite_ref-Boden_2005_11-0" class="reference"><a href="#cite_note-Boden_2005-11" title=""><span>[</span>12<span>]</span></a></sup> Both <a href="/wiki/Metformin" title="Metformin">metformin</a> and the <a href="/wiki/Thiazolidinedione" title="Thiazolidinedione">thiazolidinediones</a> improve insulin resistance, but are only approved therapies for type 2 diabetes, not insulin resistance, <i>per se</i>. By contrast, <a href="/wiki/Growth_hormone_treatment" title="Growth hormone treatment">growth hormone replacement therapy</a> may be associated with increased insulin resistance.<sup id="cite_ref-Bramnert_2003_12-0" class="reference"><a href="#cite_note-Bramnert_2003-12" title=""><span>[</span>13<span>]</span></a></sup> Metformin has become one of the more commonly prescribed medications for insulin resistance, and currently a newer drug, <a href="/wiki/Exenatide" title="Exenatide">exenatide</a> (marketed as Byetta), is being used. Exenatide has not been approved except for use in diabetics, but often improves insulin resistance by the same mechanism as it does diabetes. It also has been used to aid in weight loss for diabetics and those with insulin resistance, and is being studied for this use as well as for weight loss in people who have gained weight while on antidepressants.</p>
<p>The <i>Diabetes Prevention Program</i> showed that exercise and diet were nearly twice as effective as <a href="/wiki/Metformin" title="Metformin">metformin</a> at reducing the risk of progressing to type 2 diabetes.<sup id="cite_ref-Knowler_2002_13-0" class="reference"><a href="#cite_note-Knowler_2002-13" title=""><span>[</span>14<span>]</span></a></sup></p>
<p>Many people with insulin resistance currently follow the lead of some diabetics, and add cinnamon in therapeutic doses to their diet to help control blood sugar. This has the danger of increasing the risk of bleeding, since most commercial cinnamon preparations are actually from <i><a href="/wiki/Cassia" title="Cassia">cassia</a></i>, which also has anticoagulants, though true <a href="/wiki/Cinnamon" title="Cinnamon">cinnamon</a> <i>cinnamomum sp. zeylonicum</i>, or <i>sp. verum</i>, does not.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>Some types of <a href="/wiki/Monounsaturated_fat" title="Monounsaturated fat">Monounsaturated fatty acids</a> and saturated fats appear to promote insulin resistance, whereas some types of <a href="/wiki/Polyunsaturated_fat" title="Polyunsaturated fat">polyunsaturated fatty acids</a> (<a href="/wiki/Omega-3" title="Omega-3" class="mw-redirect">omega-3</a>) can increase insulin sensitivity.<sup id="cite_ref-Lovejoy_2002_14-0" class="reference"><a href="#cite_note-Lovejoy_2002-14" title=""><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-Fukuchi_2004_15-0" class="reference"><a href="#cite_note-Fukuchi_2004-15" title=""><span>[</span>16<span>]</span></a></sup><sup id="cite_ref-Storlien_1996_16-0" class="reference"><a href="#cite_note-Storlien_1996-16" title=""><span>[</span>17<span>]</span></a></sup></p>
<p>There are scientific studies showing that vanadium (e.g., as <a href="/wiki/Vanadyl_sulfate" title="Vanadyl sulfate">vanadyl sulfate</a>) and chromium (e.g., in <a href="/wiki/Chromium_picolinate" title="Chromium picolinate" class="mw-redirect">chromium picolinate</a> and GTF formulations) in reasonable doses have reportedly also shown some efficacy in improving IR sensitivity, but these effects are controversial.</p>
<p>Naturopathic approaches to insulin resistance have been advocated including supplementation of vanadium (but see preceding paragraph), bitter melon (<a href="/wiki/Momordica" title="Momordica">Momordica</a>, but reportedly dangerous if not used with care), and <a href="/wiki/Gymnema_sylvestre" title="Gymnema sylvestre">Gymnema sylvestre</a>.<sup id="cite_ref-Harinantenaina_2006_17-0" class="reference"><a href="#cite_note-Harinantenaina_2006-17" title=""><span>[</span>18<span>]</span></a></sup></p>
<p>One study found that chromium is necessary for maintaining normal glucose tolerance.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18" title=""><span>[</span>19<span>]</span></a></sup></p>
<p>Daily Mg administration, restoring an appropriate intracellular Mg concentration, contributes to improve insulin-mediated glucose uptake. High daily Mg intake are predictive of a lower incidence of NIDDM.</p>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=11" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>The concept that insulin resistance may be the underlying cause of <a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">diabetes mellitus</a> type 2 was first advanced by Prof. Wilhelm Falta and published in Vienna in 1931,<sup id="cite_ref-Falta_1931_19-0" class="reference"><a href="#cite_note-Falta_1931-19" title=""><span>[</span>20<span>]</span></a></sup> and confirmed by Sir <a href="/wiki/Harold_Percival_Himsworth" title="Harold Percival Himsworth">Harold Percival Himsworth</a> of the University College Hospital Medical Centre in London in 1936.<sup id="cite_ref-Himsworth_1936_20-0" class="reference"><a href="#cite_note-Himsworth_1936-20" title=""><span>[</span>21<span>]</span></a></sup></p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=12" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Chronic_Somogyi_rebound" title="Chronic Somogyi rebound">Chronic Somogyi rebound</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=13" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<ul>
<li>Symptoms list was quoted in part from various websites that are trying to educate the public about the illness, but were edited for accuracy.</li>
</ul>
<div class="references-small">
<ol class="references">
<li id="cite_note-McGarry_2002-0"><b><a href="#cite_ref-McGarry_2002_0-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMcGarry_J2002">McGarry J (2002). "Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes". <i>Diabetes</i> <b>51</b> (1): 7–18. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2337%2Fdiabetes.51.1.7" class="external text" title="http://dx.doi.org/10.2337%2Fdiabetes.51.1.7" rel="nofollow">10.2337/diabetes.51.1.7</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11756317" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11756317">PMID 11756317</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Banting+lecture+2001%3A+dysregulation+of+fatty+acid+metabolism+in+the+etiology+of+type+2+diabetes&amp;rft.jtitle=Diabetes&amp;rft.aulast=McGarry+J&amp;rft.au=McGarry+J&amp;rft.date=2002&amp;rft.volume=51&amp;rft.issue=1&amp;rft.pages=7%E2%80%9318&amp;rft_id=info:doi/10.2337%2Fdiabetes.51.1.7&amp;rft_id=info:pmid/11756317&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-1"><b><a href="#cite_ref-1" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJ_R_Flores-Riveros1993">J R Flores-Riveros (1993). <i>Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover</i>. <b>90</b>. pp. 512-516.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Insulin+down-regulates+expression+of+the+insulin-responsive+glucose+transporter+%28GLUT4%29+gene%3A+effects+on+transcription+and+mRNA+turnover&amp;rft.aulast=J+R+Flores-Riveros&amp;rft.au=J+R+Flores-Riveros&amp;rft.date=1993&amp;rft.volume=90&amp;rft.issue=2&amp;rft.pages=pp.+512-516&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-2"><b><a href="#cite_ref-2" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPaul_S._MacLean_20022002">Paul S. MacLean_2002 (2002). "Exercise-Induced Transcription of the Muscle Glucose Transporter (GLUT 4) Gene". <i>Biochemical and Biophysical Research Communications</i> <b>292</b> (2): 409-414. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1006%2Fbbrc.2002.6654" class="external text" title="http://dx.doi.org/10.1006%2Fbbrc.2002.6654" rel="nofollow">10.1006/bbrc.2002.6654</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Exercise-Induced+Transcription+of+the+Muscle+Glucose+Transporter+%28GLUT+4%29+Gene&amp;rft.jtitle=Biochemical+and+Biophysical+Research+Communications&amp;rft.aulast=Paul+S.+MacLean_2002&amp;rft.au=Paul+S.+MacLean_2002&amp;rft.date=2002&amp;rft.volume=292&amp;rft.issue=2&amp;rft.pages=409-414&amp;rft_id=info:doi/10.1006%2Fbbrc.2002.6654&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Anders_1979-3"><b><a href="#cite_ref-Anders_1979_3-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDeFronzo_R.2C_Tobin_J.2C_Andres_R1979">DeFronzo R, Tobin J, Andres R (1979). "Glucose clamp technique: a method for quantifying insulin secretion and resistance". <i>Am J Physiol</i> <b>237</b> (3): E214–23. <a href="http://www.ncbi.nlm.nih.gov/pubmed/382871" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/382871">PMID 382871</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Glucose+clamp+technique%3A+a+method+for+quantifying+insulin+secretion+and+resistance&amp;rft.jtitle=Am+J+Physiol&amp;rft.aulast=DeFronzo+R%2C+Tobin+J%2C+Andres+R&amp;rft.au=DeFronzo+R%2C+Tobin+J%2C+Andres+R&amp;rft.date=1979&amp;rft.volume=237&amp;rft.issue=3&amp;rft.pages=E214%E2%80%9323&amp;rft_id=info:pmid/382871&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Wallace_2004-4"><b><a href="#cite_ref-Wallace_2004_4-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWallace_T.2C_Levy_J.2C_Matthews_D2004">Wallace T, Levy J, Matthews D (2004). "Use and abuse of HOMA modeling". <i>Diabetes Care</i> <b>27</b> (6): 1487–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2337%2Fdiacare.27.6.1487" class="external text" title="http://dx.doi.org/10.2337%2Fdiacare.27.6.1487" rel="nofollow">10.2337/diacare.27.6.1487</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15161807" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15161807">PMID 15161807</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Use+and+abuse+of+HOMA+modeling&amp;rft.jtitle=Diabetes+Care&amp;rft.aulast=Wallace+T%2C+Levy+J%2C+Matthews+D&amp;rft.au=Wallace+T%2C+Levy+J%2C+Matthews+D&amp;rft.date=2004&amp;rft.volume=27&amp;rft.issue=6&amp;rft.pages=1487%E2%80%9395&amp;rft_id=info:doi/10.2337%2Fdiacare.27.6.1487&amp;rft_id=info:pmid/15161807&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Pham2007-5"><b><a href="#cite_ref-Pham2007_5-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPham.2C_TCornea_A.3B_Blick_KE.3B_Jenkins_A.3B_Scofield_RHMD2007">Pham, T; Cornea A; Blick KE; Jenkins A; Scofield RHMD (2007). "<a href="http://www.amjmedsci.com/pt/re/ajms/fulltext.00000441-200706000-00003.htm" class="external text" title="http://www.amjmedsci.com/pt/re/ajms/fulltext.00000441-200706000-00003.htm" rel="nofollow">Oral Glucosamine in Doses Used to Treat Osteoarthritis Worsens Insulin Resistance</a>". <i>The American Journal of the Medical Sciences</i> <b>333</b> (6): 333–339. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2FMAJ.0b013e318065bdbe" class="external text" title="http://dx.doi.org/10.1097%2FMAJ.0b013e318065bdbe" rel="nofollow">10.1097/MAJ.0b013e318065bdbe</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17570985" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17570985">PMID 17570985</a><span class="printonly">. <a href="http://www.amjmedsci.com/pt/re/ajms/fulltext.00000441-200706000-00003.htm" class="external free" title="http://www.amjmedsci.com/pt/re/ajms/fulltext.00000441-200706000-00003.htm" rel="nofollow">http://www.amjmedsci.com/pt/re/ajms/fulltext.00000441-200706000-00003.htm</a></span><span class="reference-accessdate">. Retrieved on 2007-11-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Oral+Glucosamine+in+Doses+Used+to+Treat+Osteoarthritis+Worsens+Insulin+Resistance&amp;rft.jtitle=The+American+Journal+of+the+Medical+Sciences&amp;rft.aulast=Pham%2C+T&amp;rft.au=Pham%2C+T&amp;rft.au=Cornea+A%3B+Blick+KE%3B+Jenkins+A%3B+Scofield+RHMD&amp;rft.date=2007&amp;rft.volume=333&amp;rft.issue=6&amp;rft.pages=333%E2%80%93339&amp;rft_id=info:doi/10.1097%2FMAJ.0b013e318065bdbe&amp;rft_id=info:pmid/17570985&amp;rft_id=http%3A%2F%2Fwww.amjmedsci.com%2Fpt%2Fre%2Fajms%2Ffulltext.00000441-200706000-00003.htm&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-titleEmergency_Medicine-6"><b><a href="#cite_ref-titleEmergency_Medicine_6-0" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFJeff_Unger">Jeff Unger. <a href="http://www.emedmag.com/html/pre/fea/features/101501.asp" class="external text" title="http://www.emedmag.com/html/pre/fea/features/101501.asp" rel="nofollow">"Intensive Management of Type 2 Diabetes"</a>. Emergency Medicine<span class="printonly">. <a href="http://www.emedmag.com/html/pre/fea/features/101501.asp" class="external free" title="http://www.emedmag.com/html/pre/fea/features/101501.asp" rel="nofollow">http://www.emedmag.com/html/pre/fea/features/101501.asp</a></span><span class="reference-accessdate">. Retrieved on 2008-01-13</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Intensive+Management+of+Type+2+Diabetes&amp;rft.atitle=&amp;rft.aulast=Jeff+Unger&amp;rft.au=Jeff+Unger&amp;rft.pub=Emergency+Medicine&amp;rft_id=http%3A%2F%2Fwww.emedmag.com%2Fhtml%2Fpre%2Ffea%2Ffeatures%2F101501.asp&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Solinas-7"><b><a href="#cite_ref-Solinas_7-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSolinas_Giovanni_.27.27et_al.27.272007">Solinas Giovanni <i>et al</i> (2007-11-07). "<a href="http://www.cellmetabolism.org/content/article/abstract?uid=PIIS1550413107002926" class="external text" title="http://www.cellmetabolism.org/content/article/abstract?uid=PIIS1550413107002926" rel="nofollow">JNK1 in Hematopoietically Derived Cells Contributes to Diet-Induced Inflammation and Insulin Resistance without Affecting Obesity</a>". <i>Cell Metabolism,</i> <b>6</b>: 386–397. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.cmet.2007.09.011" class="external text" title="http://dx.doi.org/10.1016%2Fj.cmet.2007.09.011" rel="nofollow">10.1016/j.cmet.2007.09.011</a></span><span class="printonly">. <a href="http://www.cellmetabolism.org/content/article/abstract?uid=PIIS1550413107002926" class="external free" title="http://www.cellmetabolism.org/content/article/abstract?uid=PIIS1550413107002926" rel="nofollow">http://www.cellmetabolism.org/content/article/abstract?uid=PIIS1550413107002926</a></span><span class="reference-accessdate">. Retrieved on 2008-01-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=JNK1+in+Hematopoietically+Derived+Cells+Contributes+to+Diet-Induced+Inflammation+and+Insulin+Resistance+without+Affecting+Obesity&amp;rft.jtitle=Cell+Metabolism%2C&amp;rft.aulast=Solinas+Giovanni+%27%27et+al%27%27&amp;rft.au=Solinas+Giovanni+%27%27et+al%27%27&amp;rft.date=2007-11-07&amp;rft.volume=6&amp;rft.pages=386%E2%80%93397&amp;rft_id=info:doi/10.1016%2Fj.cmet.2007.09.011&amp;rft_id=http%3A%2F%2Fwww.cellmetabolism.org%2Fcontent%2Farticle%2Fabstract%3Fuid%3DPIIS1550413107002926&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-titleDiabetes_News_from_dLife.com:_UCSD_Researchers_Discover_Inflammation.2C_Not_Obesity.2C_Cause_of_Insulin_Resistance-8"><b><a href="#cite_ref-titleDiabetes_News_from_dLife.com:_UCSD_Researchers_Discover_Inflammation.2C_Not_Obesity.2C_Cause_of_Insulin_Resistance_8-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.dlife.com/diabetes-news/2007/11/ucsd_researchers_discover_infl.html" class="external text" title="http://www.dlife.com/diabetes-news/2007/11/ucsd_researchers_discover_infl.html" rel="nofollow">"UCSD Researchers Discover Inflammation, Not Obesity, Cause of Insulin Resistance"</a><span class="printonly">. <a href="http://www.dlife.com/diabetes-news/2007/11/ucsd_researchers_discover_infl.html" class="external free" title="http://www.dlife.com/diabetes-news/2007/11/ucsd_researchers_discover_infl.html" rel="nofollow">http://www.dlife.com/diabetes-news/2007/11/ucsd_researchers_discover_infl.html</a></span><span class="reference-accessdate">. Retrieved on 2008-01-12</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=UCSD+Researchers+Discover+Inflammation%2C+Not+Obesity%2C+Cause+of+Insulin+Resistance&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.dlife.com%2Fdiabetes-news%2F2007%2F11%2Fucsd_researchers_discover_infl.html&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Chiu_2004-9"><b><a href="#cite_ref-Chiu_2004_9-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFChiu_KC.2C_Chu_A.2C_Go_VL.2C_Saad_MF2004">Chiu KC, Chu A, Go VL, Saad MF (2004). "<a href="http://www.ncbi.nlm.nih.gov/pubmed/15113720" class="external text" title="http://www.ncbi.nlm.nih.gov/pubmed/15113720" rel="nofollow">Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction</a>". <i>American Journal of Clinical Nutrition</i> <b>79</b> (5): 820-825. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15113720" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15113720">PMID 15113720</a><span class="printonly">. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15113720" class="external free" title="http://www.ncbi.nlm.nih.gov/pubmed/15113720" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/15113720</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Hypovitaminosis+D+is+associated+with+insulin+resistance+and+beta+cell+dysfunction&amp;rft.jtitle=American+Journal+of+Clinical+Nutrition&amp;rft.aulast=Chiu+KC%2C+Chu+A%2C+Go+VL%2C+Saad+MF&amp;rft.au=Chiu+KC%2C+Chu+A%2C+Go+VL%2C+Saad+MF&amp;rft.date=2004&amp;rft.volume=79&amp;rft.issue=5&amp;rft.pages=820-825&amp;rft_id=info:pmid/15113720&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F15113720&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> J Hong1, R R Smith, A E Harvey and N P Núñez <a href="http://www.nature.com/ijo/journal/v33/n2/abs/ijo2008266a.html" class="external text" title="http://www.nature.com/ijo/journal/v33/n2/abs/ijo2008266a.html" rel="nofollow">Alcohol consumption promotes insulin sensitivity without affecting body fat levels</a> <i>International Journal of Obesity</i> (2009) 33, 197–203; doi:10.1038/ijo.2008.266</li>
<li id="cite_note-Boden_2005-11"><b><a href="#cite_ref-Boden_2005_11-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBoden_G.2C_Sargrad_K.2C_Homko_C.2C_Mozzoli_M.2C_Stein_TP2005">Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP (2005). "<a href="http://www.ncbi.nlm.nih.gov/pubmed/15767618" class="external text" title="http://www.ncbi.nlm.nih.gov/pubmed/15767618" rel="nofollow">Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes</a>". <i>Annals of Internal Medicine</i> <b>142</b> (6): 403-411. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15767618" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15767618">PMID 15767618</a><span class="printonly">. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15767618" class="external free" title="http://www.ncbi.nlm.nih.gov/pubmed/15767618" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/15767618</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+a+low-carbohydrate+diet+on+appetite%2C+blood+glucose+levels%2C+and+insulin+resistance+in+obese+patients+with+type+2+diabetes&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.aulast=Boden+G%2C+Sargrad+K%2C+Homko+C%2C+Mozzoli+M%2C+Stein+TP&amp;rft.au=Boden+G%2C+Sargrad+K%2C+Homko+C%2C+Mozzoli+M%2C+Stein+TP&amp;rft.date=2005&amp;rft.volume=142&amp;rft.issue=6&amp;rft.pages=403-411&amp;rft_id=info:pmid/15767618&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F15767618&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Bramnert_2003-12"><b><a href="#cite_ref-Bramnert_2003_12-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBramnert_M.2C_Segerlantz_M.2C_Laurila_E.2C_Daugaard_JR.2C_Manhem_P.2C_Groop_L2003">Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L (2003). "<a href="http://jcem.endojournals.org/cgi/content/full/88/4/1455" class="external text" title="http://jcem.endojournals.org/cgi/content/full/88/4/1455" rel="nofollow">Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle</a>". <i>The Journal Of Clinical Endocrinology &amp; Metabolism</i> <b>88</b> (4): 1455–1463. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1210%2Fjc.2002-020542" class="external text" title="http://dx.doi.org/10.1210%2Fjc.2002-020542" rel="nofollow">10.1210/jc.2002-020542</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12679422" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12679422">PMID 12679422</a><span class="printonly">. <a href="http://jcem.endojournals.org/cgi/content/full/88/4/1455" class="external free" title="http://jcem.endojournals.org/cgi/content/full/88/4/1455" rel="nofollow">http://jcem.endojournals.org/cgi/content/full/88/4/1455</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Growth+hormone+replacement+therapy+induces+insulin+resistance+by+activating+the+glucose-fatty+acid+cycle&amp;rft.jtitle=The+Journal+Of+Clinical+Endocrinology+%26+Metabolism&amp;rft.aulast=Bramnert+M%2C+Segerlantz+M%2C+Laurila+E%2C+Daugaard+JR%2C+Manhem+P%2C+Groop+L&amp;rft.au=Bramnert+M%2C+Segerlantz+M%2C+Laurila+E%2C+Daugaard+JR%2C+Manhem+P%2C+Groop+L&amp;rft.date=2003&amp;rft.volume=88&amp;rft.issue=4&amp;rft.pages=1455%E2%80%931463&amp;rft_id=info:doi/10.1210%2Fjc.2002-020542&amp;rft_id=info:pmid/12679422&amp;rft_id=http%3A%2F%2Fjcem.endojournals.org%2Fcgi%2Fcontent%2Ffull%2F88%2F4%2F1455&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Knowler_2002-13"><b><a href="#cite_ref-Knowler_2002_13-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKnowler_WC.2C_Barrett-Connor_E.2C_Fowler_SE.2C_Hamman_RF.2C_Lachin_JM.2C_Walker_EA.2C_Nathan_DM.3B_Diabetes_Prevention_Program_Research_Group2002">Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group (2002). "<a href="http://content.nejm.org/cgi/content/abstract/346/6/393" class="external text" title="http://content.nejm.org/cgi/content/abstract/346/6/393" rel="nofollow">Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</a>". <i><a href="/wiki/New_England_Journal_of_Medicine" title="New England Journal of Medicine">New England Journal of Medicine</a></i> <b>346</b> (6): 393–403. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa012512" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa012512" rel="nofollow">10.1056/NEJMoa012512</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11832527" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11832527">PMID 11832527</a><span class="printonly">. <a href="http://content.nejm.org/cgi/content/abstract/346/6/393" class="external free" title="http://content.nejm.org/cgi/content/abstract/346/6/393" rel="nofollow">http://content.nejm.org/cgi/content/abstract/346/6/393</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Reduction+in+the+incidence+of+type+2+diabetes+with+lifestyle+intervention+or+metformin&amp;rft.jtitle=%5B%5BNew+England+Journal+of+Medicine%5D%5D&amp;rft.aulast=Knowler+WC%2C+Barrett-Connor+E%2C+Fowler+SE%2C+Hamman+RF%2C+Lachin+JM%2C+Walker+EA%2C+Nathan+DM%3B+Diabetes+Prevention+Program+Research+Group&amp;rft.au=Knowler+WC%2C+Barrett-Connor+E%2C+Fowler+SE%2C+Hamman+RF%2C+Lachin+JM%2C+Walker+EA%2C+Nathan+DM%3B+Diabetes+Prevention+Program+Research+Group&amp;rft.date=2002&amp;rft.volume=346&amp;rft.issue=6&amp;rft.pages=393%E2%80%93403&amp;rft_id=info:doi/10.1056%2FNEJMoa012512&amp;rft_id=info:pmid/11832527&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Fabstract%2F346%2F6%2F393&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Lovejoy_2002-14"><b><a href="#cite_ref-Lovejoy_2002_14-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLovejoy.2C_JC2002">Lovejoy, JC (2002). "The influence of dietary fat on insulin resistance". <i>Current Diabetes Reports</i> <b>2</b> (5): 435–440. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs11892-002-0098-y" class="external text" title="http://dx.doi.org/10.1007%2Fs11892-002-0098-y" rel="nofollow">10.1007/s11892-002-0098-y</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12643169" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12643169">PMID 12643169</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+influence+of+dietary+fat+on+insulin+resistance&amp;rft.jtitle=Current+Diabetes+Reports&amp;rft.aulast=Lovejoy%2C+JC&amp;rft.au=Lovejoy%2C+JC&amp;rft.date=2002&amp;rft.volume=2&amp;rft.issue=5&amp;rft.pages=435%26ndash%3B440&amp;rft_id=info:doi/10.1007%2Fs11892-002-0098-y&amp;rft_id=info:pmid/12643169&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Fukuchi_2004-15"><b><a href="#cite_ref-Fukuchi_2004_15-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFukuchi_S2004">Fukuchi S (2004). "<a href="http://www.ebmonline.org/cgi/content/full/229/6/486" class="external text" title="http://www.ebmonline.org/cgi/content/full/229/6/486" rel="nofollow">Role of Fatty Acid Composition in the Development of Metabolic Disorders in Sucrose-Induced Obese Rats</a>". <i>Experimental Biology and Medicine</i> <b>229</b> (6): 486–493. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15169967" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15169967">PMID 15169967</a><span class="printonly">. <a href="http://www.ebmonline.org/cgi/content/full/229/6/486" class="external free" title="http://www.ebmonline.org/cgi/content/full/229/6/486" rel="nofollow">http://www.ebmonline.org/cgi/content/full/229/6/486</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Role+of+Fatty+Acid+Composition+in+the+Development+of+Metabolic+Disorders+in+Sucrose-Induced+Obese+Rats&amp;rft.jtitle=Experimental+Biology+and+Medicine&amp;rft.aulast=Fukuchi+S&amp;rft.au=Fukuchi+S&amp;rft.date=2004&amp;rft.volume=229&amp;rft.issue=6&amp;rft.pages=486%26ndash%3B493&amp;rft_id=info:pmid/15169967&amp;rft_id=http%3A%2F%2Fwww.ebmonline.org%2Fcgi%2Fcontent%2Ffull%2F229%2F6%2F486&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Storlien_1996-16"><b><a href="#cite_ref-Storlien_1996_16-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFStorlien_LH1996">Storlien LH (1996). "Dietary fats and insulin action". <i>Diabetologica</i> <b>39</b> (6): 621–631. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2FBF00418533" class="external text" title="http://dx.doi.org/10.1007%2FBF00418533" rel="nofollow">10.1007/BF00418533</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8781757" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8781757">PMID 8781757</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dietary+fats+and+insulin+action&amp;rft.jtitle=Diabetologica&amp;rft.aulast=Storlien+LH&amp;rft.au=Storlien+LH&amp;rft.date=1996&amp;rft.volume=39&amp;rft.issue=6&amp;rft.pages=621%26ndash%3B631&amp;rft_id=info:doi/10.1007%2FBF00418533&amp;rft_id=info:pmid/8781757&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Harinantenaina_2006-17"><b><a href="#cite_ref-Harinantenaina_2006_17-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHarinantenaina_L2006">Harinantenaina L (2006). "<a href="http://www.jstage.jst.go.jp/article/cpb/54/7/54_1017/_article" class="external text" title="http://www.jstage.jst.go.jp/article/cpb/54/7/54_1017/_article" rel="nofollow">Momordica charantia constituents and antidiabetic screening of the isolated major compounds</a>". <i>Chemical &amp; Pharmaceutical Bulletin (Tokyo)</i> <b>54</b> (7): 1017–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1248%2Fcpb.54.1017" class="external text" title="http://dx.doi.org/10.1248%2Fcpb.54.1017" rel="nofollow">10.1248/cpb.54.1017</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16819222" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16819222">PMID 16819222</a><span class="printonly">. <a href="http://www.jstage.jst.go.jp/article/cpb/54/7/54_1017/_article" class="external free" title="http://www.jstage.jst.go.jp/article/cpb/54/7/54_1017/_article" rel="nofollow">http://www.jstage.jst.go.jp/article/cpb/54/7/54_1017/_article</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Momordica+charantia+constituents+and+antidiabetic+screening+of+the+isolated+major+compounds&amp;rft.jtitle=Chemical+%26+Pharmaceutical+Bulletin+%28Tokyo%29&amp;rft.aulast=Harinantenaina+L&amp;rft.au=Harinantenaina+L&amp;rft.date=2006&amp;rft.volume=54&amp;rft.issue=7&amp;rft.pages=1017%26ndash%3B21&amp;rft_id=info:doi/10.1248%2Fcpb.54.1017&amp;rft_id=info:pmid/16819222&amp;rft_id=http%3A%2F%2Fwww.jstage.jst.go.jp%2Farticle%2Fcpb%2F54%2F7%2F54_1017%2F_article&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-18"><b><a href="#cite_ref-18" title="">^</a></b> Article: Chromium Critical for Glucose Tolerance by Judy McBride, USDA 1999</li>
<li id="cite_note-Falta_1931-19"><b><a href="#cite_ref-Falta_1931_19-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFalta_W.2C_Boller_R1931">Falta W, Boller R (1931). "Insularer und insulinresistenter Diabetes". <i>Klin Wochenschr</i> <b>10</b>: 438–443.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Insularer+und+insulinresistenter+Diabetes&amp;rft.jtitle=Klin+Wochenschr&amp;rft.aulast=Falta+W%2C+Boller+R&amp;rft.au=Falta+W%2C+Boller+R&amp;rft.date=1931&amp;rft.volume=10&amp;rft.pages=438%26ndash%3B443&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Himsworth_1936-20"><b><a href="#cite_ref-Himsworth_1936_20-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHimsworth_HP1936">Himsworth HP (1936). "Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types". <i>Lancet</i> <b>1</b>: 127–130. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2801%2936134-2" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2801%2936134-2" rel="nofollow">10.1016/S0140-6736(01)36134-2</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Diabetes+mellitus%3A+its+differentiation+into+insulin-sensitive+and+insulin-insensitive+types&amp;rft.jtitle=Lancet&amp;rft.aulast=Himsworth+HP&amp;rft.au=Himsworth+HP&amp;rft.date=1936&amp;rft.volume=1&amp;rft.pages=127%26ndash%3B130&amp;rft_id=info:doi/10.1016%2FS0140-6736%2801%2936134-2&amp;rfr_id=info:sid/en.wikipedia.org:Insulin_resistance"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Insulin_resistance&amp;action=edit&amp;section=14" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.aafp.org/afp/20010315/1159.html" class="external text" title="http://www.aafp.org/afp/20010315/1159.html" rel="nofollow">Insulin resistance review from American Association of Family Physicians</a></li>
<li><a href="http://search.dmoz.org/cgi-bin/search?search=Insulin+resistance" class="external text" title="http://search.dmoz.org/cgi-bin/search?search=Insulin+resistance" rel="nofollow">Insulin resistance</a> at the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
<li><a href="http://www.insulinresistancecouncil.org" class="external text" title="http://www.insulinresistancecouncil.org" rel="nofollow">The National Insulin Resistance Council</a></li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:Silver" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:Silver;border:none;; font-size:xx-small;"><a href="/wiki/Template:Endocrine_pathology" title="Template:Endocrine pathology"><span title="View this template" style=";background:Silver;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Endocrine_pathology" title="Template talk:Endocrine pathology"><span title="Discussion about this template" style=";background:Silver;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Endocrine_pathology&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Endocrine_pathology&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:Silver;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Endocrinology" title="Endocrinology">Endocrine</a> <a href="/wiki/Pathology" title="Pathology">pathology</a>: <a href="/wiki/Endocrine_disease" title="Endocrine disease">endocrine diseases</a> (<a href="/wiki/ICD-10_Chapter_IV:_Endocrine,_nutritional_and_metabolic_diseases#E00-E35_-_Endocrine_diseases" title="ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases">E00-35</a>, <a href="/wiki/List_of_ICD-9_codes_240-279:_Endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders#disorders_of_thyroid_gland_.28240-246.29" title="List of ICD-9 codes 240-279: Endocrine, nutritional and metabolic diseases, and immunity disorders" class="mw-redirect">240-259</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:#efefef;;"><a href="/wiki/Pancreatic_disease" title="Pancreatic disease">Pancreas</a>/<br />
<a href="/wiki/Glucose_metabolism_disorder" title="Glucose metabolism disorder" class="mw-redirect">glucose<br />
metabolism</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#efefef;;">
<div style="padding:0em 0.75em;">Hypofunction</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">Diabetes mellitus</a> <i>types:</i> (<a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">type 1</a>, <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">type 2</a>, <a href="/wiki/Maturity_onset_diabetes_of_the_young" title="Maturity onset diabetes of the young">MODY</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Diabetes_complication" title="Diabetes complication">complications</a></i> (<a href="/wiki/Diabetic_coma" title="Diabetic coma">coma</a>, <a href="/wiki/Diabetic_angiopathy" title="Diabetic angiopathy">angiopathy</a>, <a href="/wiki/Diabetic_ketoacidosis" title="Diabetic ketoacidosis">ketoacidosis</a>, <a href="/wiki/Diabetic_nephropathy" title="Diabetic nephropathy">nephropathy</a>, <a href="/wiki/Diabetic_neuropathy" title="Diabetic neuropathy">neuropathy</a>, <a href="/wiki/Diabetic_retinopathy" title="Diabetic retinopathy">retinopathy</a>, <a href="/wiki/Diabetic_cardiomyopathy" title="Diabetic cardiomyopathy">cardiomyopathy</a>)<br />
<i>insulin receptor</i> (<a href="/wiki/Rabson-Mendenhall_syndrome" title="Rabson-Mendenhall syndrome">Rabson-Mendenhall syndrome</a>)<span style="font-weight:bold;">&#160;·</span> <strong class="selflink">Insulin resistance</strong></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#efefef;;">
<div style="padding:0em 0.75em;">Hyperfunction</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Hypoglycemia" title="Hypoglycemia">Hypoglycemia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hyperinsulinism" title="Hyperinsulinism">Hyperinsulinism</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Zollinger-Ellison_syndrome" title="Zollinger-Ellison syndrome">Zollinger-Ellison syndrome</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:#efefef;;"><a href="/wiki/Hypothalamic" title="Hypothalamic" class="mw-redirect">Hypothalamic</a>/<br />
<a href="/wiki/Pituitary" title="Pituitary" class="mw-redirect">pituitary</a> axes</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hypothalamic_disease" title="Hypothalamic disease">Hypothalamus</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Neurogenic_diabetes_insipidus" title="Neurogenic diabetes insipidus">Neurogenic diabetes insipidus</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hypothalamic_hamartoma" title="Hypothalamic hamartoma">Hypothalamic hamartoma</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Adiposogenital_dystrophy" title="Adiposogenital dystrophy">Adiposogenital dystrophy</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Kallmann_syndrome" title="Kallmann syndrome">Kallmann syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Pituitary_disease" title="Pituitary disease">Pituitary</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hyperpituitarism" title="Hyperpituitarism">Hyperpituitarism</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>anterior</i> (<a href="/wiki/Acromegaly" title="Acromegaly">Acromegaly</a>, <a href="/wiki/Hyperprolactinaemia" title="Hyperprolactinaemia">Hyperprolactinaemia</a>, <a href="/wiki/Pituitary_ACTH_hypersecretion" title="Pituitary ACTH hypersecretion">Pituitary ACTH hypersecretion</a>)<span style="font-weight:bold;">&#160;·</span> <i>posterior</i> (<a href="/wiki/Syndrome_of_inappropriate_antidiuretic_hormone" title="Syndrome of inappropriate antidiuretic hormone">SIADH</a>)<span style="font-weight:bold;">&#160;·</span> <i>general</i> (<a href="/wiki/Nelson%27s_syndrome" title="Nelson's syndrome">Nelson's syndrome</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hypopituitarism" title="Hypopituitarism">Hypopituitarism</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i>anterior</i> (<a href="/wiki/Kallmann_syndrome" title="Kallmann syndrome">Kallmann syndrome</a>, <a href="/wiki/Growth_hormone_deficiency" title="Growth hormone deficiency">Growth hormone deficiency</a>, <a href="/wiki/Adrenocorticotropic_hormone_deficiency" title="Adrenocorticotropic hormone deficiency">ACTH deficiency</a>)<span style="font-weight:bold;">&#160;·</span> <i>posterior</i> (<a href="/wiki/Neurogenic_diabetes_insipidus" title="Neurogenic diabetes insipidus">Neurogenic</a> <a href="/wiki/Diabetes_insipidus" title="Diabetes insipidus">diabetes insipidus</a>)<span style="font-weight:bold;">&#160;·</span> <i>general</i> (<a href="/wiki/Empty_sella_syndrome" title="Empty sella syndrome">Empty sella syndrome</a>, <a href="/wiki/Pituitary_apoplexy" title="Pituitary apoplexy">Pituitary apoplexy</a>, <a href="/wiki/Sheehan%27s_syndrome" title="Sheehan's syndrome">Sheehan's syndrome</a>, <a href="/wiki/Lymphocytic_hypophysitis" title="Lymphocytic hypophysitis" class="mw-redirect">Lymphocytic hypophysitis</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Thyroid_disease" title="Thyroid disease">Thyroid</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hypothyroidism" title="Hypothyroidism">Hypothyroidism</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Iodine_deficiency" title="Iodine deficiency">Iodine deficiency</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cretinism" title="Cretinism">Cretinism</a> (<a href="/wiki/Congenital_hypothyroidism" title="Congenital hypothyroidism">Congenital hypothyroidism</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Myxedema" title="Myxedema">Myxedema</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Euthyroid_sick_syndrome" title="Euthyroid sick syndrome">Euthyroid sick syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hyperthyroidism" title="Hyperthyroidism">Hyperthyroidism</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Hyperthyroxinemia" title="Hyperthyroxinemia">Hyperthyroxinemia</a> (<a href="/wiki/Thyroid_hormone_resistance" title="Thyroid hormone resistance">Thyroid hormone resistance</a>, <a href="/wiki/Familial_dysalbuminemic_hyperthyroxinemia" title="Familial dysalbuminemic hyperthyroxinemia">Familial dysalbuminemic hyperthyroxinemia</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hashitoxicosis" title="Hashitoxicosis">Hashitoxicosis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Thyrotoxicosis_factitia" title="Thyrotoxicosis factitia">Thyrotoxicosis factitia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Graves%27_disease" title="Graves' disease">Graves' disease</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Thyroiditis" title="Thyroiditis">Thyroiditis</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Acute_infectious_thyroiditis" title="Acute infectious thyroiditis">Acute infectious</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Subacute_thyroiditis" title="Subacute thyroiditis">Subacute</a> (<a href="/wiki/De_Quervain%27s_thyroiditis" title="De Quervain's thyroiditis">De Quervain's</a>, <a href="/wiki/Subacute_lymphocytic_thyroiditis" title="Subacute lymphocytic thyroiditis">Subacute lymphocytic</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Autoimmune_thyroiditis" title="Autoimmune thyroiditis">Autoimmune</a>/chronic (<a href="/wiki/Hashimoto%27s_thyroiditis" title="Hashimoto's thyroiditis">Hashimoto's</a>, <a href="/wiki/Postpartum_thyroiditis" title="Postpartum thyroiditis">Postpartum</a>, <a href="/wiki/Riedel%27s_thyroiditis" title="Riedel's thyroiditis">Riedel's</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Goitre" title="Goitre">Goitre</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Endemic_goitre" title="Endemic goitre">Endemic goitre</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Toxic_nodular_goitre" title="Toxic nodular goitre">Toxic nodular goitre</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Toxic_multinodular_goitre" title="Toxic multinodular goitre">Toxic multinodular goitre</a><br />
<a href="/wiki/Thyroid_nodule" title="Thyroid nodule">Thyroid nodule</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Parathyroid_disease" title="Parathyroid disease">Parathyroid</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hypoparathyroidism" title="Hypoparathyroidism">Hypoparathyroidism</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Pseudohypoparathyroidism" title="Pseudohypoparathyroidism">Pseudohypoparathyroidism</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hyperparathyroidism" title="Hyperparathyroidism">Hyperparathyroidism</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Primary_hyperparathyroidism" title="Primary hyperparathyroidism">Primary</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Secondary_hyperparathyroidism" title="Secondary hyperparathyroidism">Secondary</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tertiary_hyperparathyroidism" title="Tertiary hyperparathyroidism">Tertiary</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Osteitis_fibrosa_cystica" title="Osteitis fibrosa cystica">Osteitis fibrosa cystica</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Adrenal_gland_disease" title="Adrenal gland disease">Adrenal</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Adrenocortical_hyperfunction" title="Adrenocortical hyperfunction">Hyperfunction</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a>:</i> <a href="/wiki/Hyperaldosteronism" title="Hyperaldosteronism">Hyperaldosteronism</a>/<a href="/wiki/Primary_aldosteronism" title="Primary aldosteronism">Primary aldosteronism</a> (<a href="/wiki/Conn_syndrome" title="Conn syndrome" class="mw-redirect">Conn syndrome</a>, <a href="/wiki/Bartter_syndrome" title="Bartter syndrome">Bartter syndrome</a>, <a href="/wiki/Glucocorticoid_remediable_aldosteronism" title="Glucocorticoid remediable aldosteronism">Glucocorticoid remediable aldosteronism</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Apparent_mineralocorticoid_excess_syndrome" title="Apparent mineralocorticoid excess syndrome">AME</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Liddle%27s_syndrome" title="Liddle's syndrome">Liddle's syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency">17α CAH</a>
<p><i><a href="/wiki/Cortisol" title="Cortisol">cortisol</a>:</i> <a href="/wiki/Cushing%27s_syndrome" title="Cushing's syndrome">Cushing's syndrome</a> (<a href="/wiki/Pseudo-Cushing%27s_syndrome" title="Pseudo-Cushing's syndrome">Pseudo-Cushing's syndrome</a>)</p>
<i><a href="/wiki/Sex_hormone" title="Sex hormone" class="mw-redirect">sex hormones</a>:</i> <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 21-hydroxylase deficiency">21α CAH</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency">11β CAH</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#efefef;;">
<div style="padding:0em 0.75em;">Hypofunction/<br />
<a href="/wiki/Adrenal_insufficiency" title="Adrenal insufficiency">Adrenal insufficiency</a><br />
(<a href="/wiki/Addison%27s_disease" title="Addison's disease">Addison's</a>, <a href="/wiki/Waterhouse-Friderichsen_syndrome" title="Waterhouse-Friderichsen syndrome">WF</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i>aldosterone:</i> <a href="/wiki/Hypoaldosteronism" title="Hypoaldosteronism">Hypoaldosteronism</a> (<a href="/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 21-hydroxylase deficiency">21α CAH</a>, <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency">11β CAH</a>)
<p><i>cortisol:</i> <a href="/wiki/Congenital_adrenal_hyperplasia" title="Congenital adrenal hyperplasia">CAH</a> (<a href="/wiki/Lipoid_congenital_adrenal_hyperplasia" title="Lipoid congenital adrenal hyperplasia">Lipoid</a>, <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_3_beta-hydroxysteroid_dehydrogenase_deficiency" title="Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency">3β</a>, <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency">11β</a>, <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency">17α</a>, <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 21-hydroxylase deficiency">21α</a>)</p>
<i>sex hormones:</i> <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency">17α CAH</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Gonadal_disorder" title="Gonadal disorder" class="mw-redirect">Gonads</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Ovarian_disease" title="Ovarian disease">ovarian</a></i> (<a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">Polycystic ovary syndrome</a>, <a href="/wiki/Premature_ovarian_failure" title="Premature ovarian failure">Premature ovarian failure</a>)
<p><i><a href="/wiki/Testicular_disease" title="Testicular disease">testicular</a></i> (<a href="/wiki/5-alpha-reductase_deficiency" title="5-alpha-reductase deficiency">5-alpha-reductase deficiency</a>, <a href="/wiki/17-beta-hydroxysteroid_dehydrogenase_deficiency" title="17-beta-hydroxysteroid dehydrogenase deficiency">17-beta-hydroxysteroid dehydrogenase deficiency</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Androgen_receptor" title="Androgen receptor">Androgen receptor</a></i> (<a href="/wiki/Androgen_insensitivity_syndrome" title="Androgen insensitivity syndrome">Androgen insensitivity syndrome</a>)</p>
<i>general</i> (<a href="/wiki/Hypogonadism" title="Hypogonadism">Hypogonadism</a>, <a href="/wiki/Delayed_puberty" title="Delayed puberty">Delayed puberty</a>, <a href="/wiki/Precocious_puberty" title="Precocious puberty">Precocious puberty</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:#efefef;;">Height</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Gigantism" title="Gigantism">Gigantism</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Dwarfism" title="Dwarfism">Dwarfism</a>/<a href="/wiki/Short_stature" title="Short stature">Short stature</a> (<a href="/wiki/Laron_syndrome" title="Laron syndrome">Laron syndrome</a>, <a href="/wiki/Psychogenic_dwarfism" title="Psychogenic dwarfism">Psychogenic dwarfism</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:#efefef;;">Multiple</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Autoimmune_polyendocrine_syndrome" title="Autoimmune polyendocrine syndrome">Autoimmune polyendocrine syndrome</a> (<a href="/wiki/Autoimmune_polyendocrine_syndrome_type_1" title="Autoimmune polyendocrine syndrome type 1">APS1</a>, <a href="/wiki/Autoimmune_polyendocrine_syndrome_type_2" title="Autoimmune polyendocrine syndrome type 2">APS2</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Carcinoid_syndrome" title="Carcinoid syndrome">Carcinoid syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Multiple_endocrine_neoplasia" title="Multiple endocrine neoplasia">Multiple endocrine neoplasia</a> (<a href="/wiki/Multiple_endocrine_neoplasia_type_1" title="Multiple endocrine neoplasia type 1">1</a>, <a href="/wiki/Multiple_endocrine_neoplasia_type_2" title="Multiple endocrine neoplasia type 2">2A</a>, <a href="/wiki/Multiple_endocrine_neoplasia_type_2b" title="Multiple endocrine neoplasia type 2b">2B</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Progeria" title="Progeria">Progeria</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Woodhouse-Sakati_syndrome" title="Woodhouse-Sakati syndrome">Woodhouse-Sakati syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i>see also <a href="/wiki/Template:Congenital_endocrine_disorders" title="Template:Congenital endocrine disorders">congenital</a>, <a href="/wiki/Template:Endocrine_gland_neoplasia" title="Template:Endocrine gland neoplasia">neoplasia</a></i></div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 12407/1000000
Post-expand include size: 200207/2048000 bytes
Template argument size: 108333/2048000 bytes
Expensive parser function count: 1/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:54448-0!1!0!default!!en!2 and timestamp 20090404171629 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Insulin_resistance">http://en.wikipedia.org/wiki/Insulin_resistance</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Diabetes" title="Category:Diabetes">Diabetes</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_December_2008" title="Category:Articles with unsourced statements since December 2008">Articles with unsourced statements since December 2008</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Insulin_resistance" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Insulin_resistance" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Insulin_resistance&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Insulin_resistance&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Insulin_resistance" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Insulin_resistance" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Insulin_resistance" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Insulin_resistance&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Insulin_resistance&amp;oldid=276088448" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Insulin_resistance&amp;id=276088448">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-af"><a href="http://af.wikipedia.org/wiki/Insulienweerstandigheid">Afrikaans</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Insulinresistenz">Deutsch</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/R%C3%A9sistance_%C3%A0_l%27insuline">Français</a></li>
				<li class="interwiki-ko"><a href="http://ko.wikipedia.org/wiki/%EC%9D%B8%EC%8A%90%EB%A6%B0_%EC%A0%80%ED%95%AD%EC%84%B1">한국어</a></li>
				<li class="interwiki-id"><a href="http://id.wikipedia.org/wiki/Penolakan_insulin">Bahasa Indonesia</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E3%82%A4%E3%83%B3%E3%82%B9%E3%83%AA%E3%83%B3%E6%8A%B5%E6%8A%97%E6%80%A7">日本語</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Insulinooporno%C5%9B%C4%87">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Resist%C3%AAncia_%C3%A0_insulina">Português</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Insuliiniresistenssi">Suomi</a></li>
				<li class="interwiki-tr"><a href="http://tr.wikipedia.org/wiki/%C4%B0ns%C3%BClin_direnci">Türkçe</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E8%83%B0%E5%B2%9B%E7%B4%A0%E6%8A%B5%E6%8A%97">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 9 March 2009, at 18:51.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv190 in 0.423 secs. --></body></html>
